Health · Medical Research · 3 hrs ago

Scientists propose targeting GPCRs to delay multiple diseases of aging

Scientists propose targeting GPCRs to delay multiple diseases of aging

Researchers led by Stuart Maudsley of the Moffitt Cancer Center in Tampa propose rebalancing GPCRs to target several diseases of aging.

GPCRs are receptors on cell surfaces that pass signals into cells, and many existing medicines already target them.

The proposal focuses on heart disease, type 2 diabetes and Alzheimer’s, which are often treated as separate conditions.

The researchers argue that changes in GPCRs are linked to shared aging processes, including inflammation and weakening cell functions.

They propose adjusting different receptor signals rather than turning all GPCR activity up or down.

No drug or drug combination has been tested for slowing aging through this approach.

The authors say the idea is practical because many GPCRs can already be targeted with medicines, but it remains a plan to test, not a proven treatment.

1 source

Related

What people are saying

Stuart MaudsleySenior author and pharmacologist
Our argument is not that GPCRs have already been shown to outperform every other approach
via Earth.com
It is that they offer an unusually practical set of entry points into this interconnected biology, because we already know how to target many of them with medicines
via Earth.com
Crucially, this is not about switching all GPCR activity up or down
via Earth.com